mexidol
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
3
Phase 4
2
Earliest trial started Jul 13, 2019 (NCT06854601)
Timeline
Indications
Approved for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mexidol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06437639 | Phase 4 | Sep 15, 2023 | Pharmasoft |
| NCT06221826 | Phase 4 | Apr 17, 2023 | Pharmasoft |
| NCT06903156 | Phase 2 | Nov 15, 2021 | Pharmasoft |
| NCT06437626 | Phase 3 | Nov 18, 2019 | Pharmasoft |
| NCT06834490 | Phase 3 | Nov 5, 2019 | Pharmasoft |
| NCT06854601 | Phase 3 | Jul 13, 2019 | Pharmasoft |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pharmasoft | For profit | 6 | 6 | 3 | 2019 |
1 organizations
Page 1 / 1